Submitted by Anonymous (not verified) on 5 August 2026 - 15:26
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 5, Status: Authorised